Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.100 |
None |
0.974 |
116 |
1
|
2000 |
2020 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.100 |
None |
0.974 |
114 |
1
|
2000 |
2020 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
13 |
|
2002 |
2018 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.909 |
11 |
|
2003 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
0.909 |
11 |
|
2003 |
2019 |
Waist-Hip Ratio
|
phenotype |
|
Organism Attribute
|
565
|
1138
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Dental caries
|
disease |
Stomatognathic Diseases
|
Disease or Syndrome
|
330
|
126
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
White Blood Cell Count procedure
|
phenotype |
|
Laboratory Procedure
|
681
|
1322
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Hippocampal atrophy
|
phenotype |
|
Finding
|
13
|
12
|
0.100 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Benign Prostatic Hyperplasia
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
770
|
91
|
0.090 |
None |
1.000 |
9 |
|
2005 |
2019 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.090 |
None |
1.000 |
9 |
|
2002 |
2017 |
High-Grade Prostatic Intraepithelial Neoplasia
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
111
|
|
0.040 |
None |
1.000 |
4 |
|
2010 |
2015 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.030 |
None |
1.000 |
3 |
|
2009 |
2015 |
aggressive cancer
|
phenotype |
|
Neoplastic Process
|
83
|
5
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2019 |
Metastasis from malignant tumor of prostate
|
disease |
|
Neoplastic Process
|
342
|
18
|
0.010 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Carcinoma, Ovarian Epithelial
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2841
|
327
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Metastatic Prostate Carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
362
|
24
|
0.010 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Hormone refractory prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
683
|
29
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Salivary Gland Pleomorphic Adenoma
|
disease |
Neoplasms; Stomatognathic Diseases
|
Neoplastic Process
|
63
|
9
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Malignant transformation
|
phenotype |
|
Neoplastic Process
|
1027
|
20
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
CATARACT, ANTERIOR POLAR
|
disease |
Eye Diseases
|
Disease or Syndrome
|
125
|
27
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Alzheimer disease, familial, type 3
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
213
|
124
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |